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Small unilamelar vesicleAccording to current models, most newly synthesized peroxisomal intrinsic membrane proteins are
recognized in the cytosol and targeted to the peroxisomal membrane by PEX19. At the organelle membrane
the PEX19-cargo protein complex interacts with PEX3, a protein believed to possess only one transmembrane
domain and exposing the majority of its polypeptide chain into the cytosol. In agreement with this topological
model, a recombinant protein comprising the cytosolic domain of PEX3 can be puriﬁed in a soluble and
monomeric form in the absence of detergents or other solubilizing agents. Here, we show that this
recombinant protein actually precipitates when incubated with mild detergents, suggesting that this domain
of PEX3 interacts with amphipathic molecules. Following this observation, we tested this recombinant protein
in lipid-binding assays and found that it interacts strongly with liposomes inducing their ﬂocculation or even
partial solubilization. The implications of these ﬁndings are discussed.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Peroxisomes are single membrane-bound organelles found in
nearly all eukaryotic organisms [1]. In mammals they are involved in
several important metabolic pathways including the β-oxidation of
fatty acids, synthesis of etherglycerophospholipids and bile acids, the
catabolism of some amino acids and polyamines and detoxiﬁcation of
reactive oxygen species [2,3]. About 100 different proteins, many of
which are expressed in a tissue-dependent manner, are found in these
organelles [4–7].
Peroxisomal proteins are synthesized in the cytosol and sorted into
the organelle by one of two machineries. Proteins destined to the
matrix of the organelle require an intricate machinery comprising
more than a dozen components to reach their ﬁnal location [8,9]. In
contrast, only three proteins, PEX3, PEX16 and PEX19, have been
implicated in the sorting pathway of peroxisomal intrinsic membrane
proteins (PMPs) [10,11]. Whereas participation of both PEX3 and
PEX19 in the PMP sorting pathway is a generally accepted notion, thattein; SUVs, small unilamelar
romatography; TLC, thin layer
th a phospholipid composition
PC/PE/PI/PS, phosphatidyl-
ly
cular e Celular (IBMC), Uni-
80 Porto, Portugal. Tel.: +351
.
ll rights reserved.of PEX16 remains uncertain. Actually, in Yarrowia lipolytica PEX16 is
involved in the process of peroxisome proliferation and not in PMP
biogenesis [12]. Furthermore, unlike PEX3 and PEX19, PEX16 does
not exist in all peroxisome-containing organisms including baker's
yeast [13].
PEX19 is an acidic and soluble protein displaying a high content of
disordered structure [14]. It binds newly synthesized PMPs in the
cytosol during or shortly after their synthesis and transports them to
the peroxisomal membrane [14–17]. Here, the PEX19–PMP protein
complex interacts with PEX3. It is presently believed that PEX3 is an
intrinsic component of this membrane system possessing one
transmembrane domain near its N terminus and exposing the
majority of its polypeptide chain into the cytosol [18,19] (see also
Discussion). The interaction of the PEX19–PMP protein complex with
PEX3 ultimately results in the insertion of the PMP into the organelle
membrane, an event that does not involve hydrolysis of ATP [16,20–
22]. Finally, somewhere during this process PEX19 is released back
into the cytosol in order to promote further cycles of protein
transportation.
If the basic aspects of the PMP sorting pathway seem to be
reasonably comprehended, the same cannot be said regarding the
mechanistic details of the protein membrane insertion step. How are
hydrophobic cargo proteins transferred from a soluble cytosolic
protein complex into the hydrophobic phase of the peroxisomal
membrane? How are matrix-exposed hydrophilic domains of PMPs
translocated across the peroxisomal membrane? Is there a hydro-
philic channel with lateral access to the membrane lipid environ-
ment? Is the role of PEX19 and PEX3 related to any of these processes
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proteins at the surface of the peroxisomal membrane?
In this work we show that a recombinant protein comprising the
cytosolic portion of PEX3, the domain that binds PEX19–PMP
complexes [14,16], interacts strongly with membrane lipids. We
propose that one of the functions of this protein is to perturb the
peroxisomal lipid bilayer to allow the PMP membrane insertion
process.
2. Materials and methods
2.1. Recombinant proteins
Histidine-tagged human PEX3(34–373) [16] and ΔC1-PEX5,
comprising amino acid residues 1–324 of human PEX5 [23], were
expressed in the Escherichia coli BL21 (DE3) strain, whereas human
PEX19 was expressed in the M15 strain [24]. Puriﬁcation of the
recombinant proteins with Ni-NTA agarose was performed as
described in [16] and [25].
2.2. Small unilamelar vesicles (SUVs) preparation
SUVs were prepared using a protocol adapted from [26] and [27].
Brieﬂy, phospholipids (Sigma) were resuspended in chloroform,
mixed into the desired composition and dried under a nitrogen
stream. The dried phospholipids were additionally lyophilized
overnight. The phospholipid ﬁlms were hydrated in SUVs buffer
(10 mM Tris–HCl, pH 7.5, 100 mM NaCl, 0.5 mM EDTA–NaOH, pH 7.5)
at 4 mg/ml ﬁnal concentration. After shaking for 30 min at 37 °C, the
suspension was vortexed for 2 min, subjected to ﬁve freeze (N2(l))/
thaw (37 °C) cycles, sonicated and centrifuged at 10,000 g for 5min to
remove metal traces from the sonicator. Liposome suspensions were
kept at 4 °C and used within 24 h.
2.3. Native polyacrylamide gel electrophoresis
Recombinant PEX3(34–373) was incubated with SUVs of different
phospholipid composition or with Triton X-100 for 30 min at room
temperature (RT) in 20 μl of 50mMTris–HCl, pH 8.0, 2mMDTT. At the
end of the incubation, the samples received 2 μl of 0.17% (w/v)
bromphenol blue, 50% (w/v) sucrose and were loaded onto Tris
nondenaturing discontinuous 9% polyacrylamide gels [28]. The gels
were run at 250 V at 4 °C and stained with Coomassie Brilliant Blue
R-250.
2.4. Floatation assays
Recombinant PEX3(34–373) or ΔC1-PEX5 (65 μg) were incubated
alone or with SUVs (325 μg) in 200 μl of SUVs buffer supplemented
with 1 mM DTT for 2 h at 37 °C. Recombinant human PEX19 (195 μg)
was incubated with SUVs (325 μg) alone or together with PEX3(34–
373) (65 μg) under the same conditions. The samples were then
mixed with 1.8 ml of 58% (w/v) Optiprep (Sigma) in SUVs buffer,
applied onto the bottom of centrifuge tubes and carefully overlaid
with 4 ml of 48% (w/v) Optiprep and 4 ml of 0% (w/v) Optiprep in
SUVs buffer. The gradients were centrifuged at 160,000 g for 14 h at
12 °C in a Beckman SW41 rotor. The following fractions were collected
from the top of the gradients: 0% (w/v) Optiprep solution plus the 0–
48% (w/v) Optiprep interface (top fraction), 48% (w/v) Optiprep
solution (middle fraction) and 48–52% (w/v) Optiprep interface
together with the 52% (w/v) Optiprep solution plus pellet (bottom
fraction). Equivalent volumes (corresponding to 5 μg of PEX3(34–
373) or ΔC1-PEX5) were analyzed by SDS-PAGE after trichloroacetic
acid precipitation. Equivalents to 10 μg of phospholipids were
extracted from the gradient fractions according to Folch's method
[29] and analyzed by thin layer chromatography (TLC).2.5. Protease protection assays and alkaline extraction
Recombinant PEX3(34–373) was incubated with per-SUVs or PI-
SUVs as described in Section 2.4. The samples were halved and one
half received proteinase K (400 μg/ml ﬁnal concentration). After
30 min on ice, phenylmethanesulfonyl ﬂuoride (500 μg/ml) was
added and the samples placed on ice for another 2 min. Samples were
precipitated with trichloroacetic acid and equivalents to 10 μg of PEX3
(34–373) analyzed by SDS-PAGE.
Recombinant PEX3(34–373) alone or pre-incubated with per-
SUVs was diluted 5-fold with alkaline 0.15 M Na2CO3 and incubated
on ice for 30 min [30]. The samples were halved and one half was kept
on ice while the other was separated into pellet and soluble fraction
by centrifugation (135,000 g at 4 °C for 2 h). After trichloroacetic acid
precipitation samples were analyzed by SDS-PAGE.
2.6. Size exclusion chromatography (SEC)
Recombinant PEX3(34–373) (50 μg), PI-SUVs (250 μg) or PEX3
(34–373) plus PI-SUVs were incubated for 2 h at 37 °C in 500 μl of
SUVs buffer supplemented with 1 mM DTT. Samples were subjected
to a low speed centrifugation (10,000 g for 10 min) and the clariﬁed
supernatants were injected into a Superose 6 10/300 GL column
(Amersham Biosciences) running with the same buffer at a 0.5 ml/
min ﬂow rate at 4 °C. The column was calibrated with the following
standards (numbers in parentheses indicate the respective Stokes
radius): thyroglobulin (Thy; 8.5 nm), bovine serum albumin (BSA;
3.6 nm) and soybean trypsin inhibitor (STI; 2.3 nm). Fractions of 1 ml
were collected. One fourth of each fraction was supplemented
with 2 μg of BSA, subjected to trichloroacetic acid precipitation
and analyzed by SDS-PAGE; one ﬁfth was lyophilized and analyzed
by TLC.
2.6. TLC analysis of lipids
Lipids dissolved in 30 μl of chloroformwere applied to HPTLC Silica
Gel 60 plates (Merck) previously activated at 100 °C for 1 h. After
development with chloroform/methanol/acetic acid/formic acid/
water (35:15:6:2:1), the plates were dried with a hair dryer. Lipids
were visualized by spraying with 1% anisaldehyde in 80% (v/v)
sulfuric acid followed by heating for 30 min at 120 °C.
3. Results
Histidine-tagged human PEX3 cannot be produced in E. coli cells
probably because of its toxicity. In contrast, large amounts of a
truncated version of PEX3 [PEX3(34–373)] lacking just the ﬁrst 33
amino acid residues, a region comprising a putative transmembrane
domain, can be easily obtained [14,16,31], although only about half of
the total recombinant protein is recovered in a soluble state (see Fig.
S1 in Supplementary Data). Nevertheless, this soluble pool of
recombinant PEX3(34–373) is monodisperse as assessed by both
size exclusion chromatography and native-PAGE [16,31] (see also
below). Strikingly, its solubility vanishes in the presence of mild
detergents. For instance, Triton X-100 even at concentrations close to
its critical micellar concentration induces aggregation of the protein
as assessed by native-PAGE (Fig. 1, odd numbered lanes) or
centrifugation (not shown). Interestingly, recombinant human
PEX19 partially protects PEX3(34–373) from detergent-induced
aggregation as inferred from the fact that small amounts of both
monomeric PEX3(34–373) and PEX3(34–373)-PEX19 complex can
still be detected even at high detergent concentrations (Fig. 1, even
numbered lanes). The majority of PEX3(34–373), however, is
detected as oligomers.
The observation that PEX3(34–373) interacts with detergents led
us to hypothesize that the same could be true for other amphipathic
Fig. 1. PEX3(34-373) forms aggregates in the presence of Triton X-100. Recombinant
PEX3(34–373) (3 μg/lane) was incubated with increasing amounts of Triton X-100 (0,
0.01, 0.025, 0.05, 0.1 and 0.5 % (w/v)) in the absence (odd numbered lanes) or presence
of recombinant PEX19 (6 μg/lane) (even numbered lanes) for 30 min at RT and
subjected to native-PAGE. A Coomassie Blue-stained gel is shown. The arrows indicate
the gel migration of recombinant PEX3(34–373) (P3), recombinant PEX19 (P19) and
the complex between them (P19-P3; see also Fig. S2). The arrowhead indicates the
stacking/separation gel interface.
Fig. 2. The electrophoretic mobility of native PEX3(34–373) is altered after incubation
with SUVs. SUVs mimicking the phospholipid composition of the peroxisomal
membrane (per-SUVs; upper panel) or made of pure PI (PI-SUVs; middle panel) or
pure PS (PS-SUVs; lower panel) were incubated with 2 μg of recombinant PEX3(34–
373) at increasing lipid:protein ratios (0, 0.125, 0.625, 2.5, 5 and 25 (w/w)) for 30 min
at RT. The samples were subjected to native-PAGE analysis followed by staining with
Coomassie Brilliant Blue R-250. The arrowhead indicates the stacking/separation gel
interface.
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idea, PEX3(34–373) was incubated with small unilamelar vesicles
(SUVs) of different phospholipid compositions at several lipid:protein
ratios and subjected to native-PAGE. Fig. 2 (upper panel) shows the
results obtained with SUVs made of PC/PE/PI/PS at a 54:36:5:5 molar
ratio (hereafter referred to as per-SUVs), a phospholipid composition
mimicking the one of themammalian peroxisomal membrane [32]. At
lipid:protein ratios of 5–25 (w/w) a signiﬁcant fraction of PEX3(34–
373) was retained both at the well and at the interface of the stacking
and separation gels suggesting that protein-lipid interactions did
occur (Fig. 2, upper panel). The lipid-induced effect on the
electrophoretic migration of PEX3(34–373) seemed to depend on
the acidic phospholipid content of the SUVs because it was detectable
at lower lipid:protein ratios when using SUVs comprising PC/PE/PI/
PS at a 42:28:15:15 molar ratio (data not shown). In agreement with
this interpretation, incubation of PEX3(34–373) with SUVs made of
pure PI (hereafter referred to as PI-SUVs) or pure PS (PS-SUVs)
induced electrophoretic effects on the recombinant protein at very
low lipid:protein ratios (Fig. 2, middle and lower panels, respectively).
The results obtained with PI-SUVs are particularly interesting. In
addition to the material staying at the wells and at the top of the
separation gel, discrete populations of PEX3(34–373) entering the
separation gel, one of which migrates even faster than the protein
alone, were also observed. As explained below, it is probable that
these populations represent lipoprotein particles of a bicellar/micellar
nature.
To address the lipid-binding properties of recombinant PEX3(34–
373) under physiologically relevant conditions we employed a
centrifugation ﬂoatation assay. Due to the fact that much larger
volumes of protein:lipid mixtures were used here than in the native-
PAGE analysis, these experiments also revealed that incubation of
PEX3(34–373) with per-SUVs results in a massive ﬂocculation of the
SUVs. Upon centrifugation these ﬂoccules ﬂoated to the top fraction of
the gradients and, importantly, so did the majority of PEX3(34–373)
(Fig. 3A, lane T in the central panel). No such ﬂoccules were observed
when using human PEX19 or a control His-tagged protein, ΔC1-PEX5,
recombinant proteins for which we could not detect lipid-binding
activities by native-PAGE (data not shown). In the PEX19 and ΔC1-
PEX5 samples, the SUVs were also found at the top fraction of the
gradients but these SUVs contained no recombinant protein (Fig. 3B
and C, respectively). Thus, ﬂoatation of PEX3(34–373) in these
gradients is not due to encapsulation of the recombinant proteininto liposomes, a phenomenon that might be induced by sample
manipulation (e.g., pipetting) or by the large changes in the
hydrostatic pressure generated during centrifugation. The fact that
per-SUVs-bound PEX3(34–373) displays no resistance to exogenously
added proteinase K corroborates this interpretation (see Fig. 4A).
Interestingly, the interaction of PEX3(34–373) with per-SUVs is not
disrupted by alkaline treatment (see Fig. 4B). Taken together these
data suggest that no large domain of PEX3(34–373) is translocated
across the per-SUVs membrane during the protein-lipid association
process; rather, it seems that one or more small domains of the
recombinant protein become embedded in the hydrophobic milieu of
the lipid bilayer.
The lipid-binding activity of PEX3(34–373) pre-incubated with
recombinant PEX19 was also characterized. Incubation of per-SUVs
with this protein mixture did not result in the formation of ﬂoccules.
Upon ﬂoatation these SUVs were found at the top fraction of the
Fig. 3. Centrifugation ﬂoatation assay of PEX3(34–373). (A) Recombinant PEX3(34–
373) (P3) and (C) ΔC1-PEX5 (ΔC1) were incubated alone or with SUVs for 2 h at 37 °C.
(B) Recombinant PEX19 (P19) was incubated with PEX3(34–373) plus per-SUVs or
with only per-SUVs or PI-SUVs. The samples were then subjected to ﬂoatation on
discontinuous Optiprep gradients. The gradients were fractionated into bottom (B),
middle (M) and top (T) fractions (see Materials and methods) and analyzed by SDS-
PAGE and TLC. The asterisk indicates a dimer of PEX3(34–373) induced by heating in
SDS sample buffer (see also [31]). Phosphatidyl-choline (PC), -inositol (PI) and
-ethanolamine (PE) are indicated. Note that per-SUVs contain low amounts of PI and PS
and therefore these lipids are not visible in these analyses. Numbers at the left indicate
the molecular masses of the protein standards in kDa.
Fig. 4. Properties of lipid-associated PEX3(34–373). (A) Recombinant PEX3(34–373)
(P3) pre-incubated with either per-SUVs or PI-SUVs was incubated in the absence
(lanes -) or in the presence (lanes +) of proteinase K (PK) for 30 min on ice. After
inactivation of the protease, equivalents to 10 μg of PEX3(34–373) were analyzed by
SDS-PAGE. A control sample (C) containing proteinase K but lacking PEX3(34–373) was
also analyzed. (B) PEX3(34–373) (P3) alone or pre-incubated with per-SUVs was
subjected to alkaline treatment (see Materials and methods). Samples were halved and
one half was kept on ice (lanes T) while the other was separated into pellet (lanes P)
and soluble fraction (lanes S) by centrifugation. Samples were precipitated with
trichloroacetic acid and equivalents to 10 μg of PEX3(34–373) analyzed by SDS-PAGE.
The asterisk indicates PEX3(34–373) dimers (see legend to Fig. 3). Numbers at the left
indicate the molecular masses of protein standards in kDa.
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Apparently, binding of lipids and PEX19 by this domain of PEX3 are
mutually exclusive events (see Discussion).Incubation of PEX3(34–373) with PI-SUVs did not change the
macroscopic properties of the lipid suspension. Upon centrifugation
the majority of the lipids ﬂoated to top fraction of the gradients (Fig.
3A, right panel). Interestingly, only a minor fraction of PEX3(34–373)
ﬂoated to the top of the gradient; most of the recombinant protein
was found at the bottom and middle fractions. SEC analysis of this
protein/lipid mixture provides the explanation for this ﬁnding. The
experimental conditions used here were exactly the ones employed in
the ﬂoatation experiments with the exception that Optiprep was
excluded from the buffer and the samples were subjected to a
clarifying spin immediately before injecting them into the column to
avoid clogging problems. About one fourth of the recombinant PEX3
(34–373) was removed in this clarifying spin (not shown). As shown
in Fig. 5, PEX3(34–373) alone eluted in a single symmetric peak after
BSA (67 kDa) and before STI (20 kDa) illustrating the monodispersity
of this recombinant protein and its monomeric status. Similar data
were provided recently [31]. Protein-free PI-SUVs eluted in the void
volume of the column, as expected from their large dimensions [33].
The chromatogram of PI-SUVs incubated with PEX3(34–373) shows
two absorbance/light scattering peaks, one at the void volume and
the other, quite broad in shape, centered in fraction 7. Both peaks
contain PI as demonstrated by TLC analysis of the gradient fractions
but only the one centered in fraction 7 contains also PEX3(34–373).
This result indicates that PEX3(34–373) forms lipoprotein particles
when incubated with PI, in good agreement with the native-PAGE
analysis (see Fig. 2). The small size of these particles (stokes radii of
5–9 nm) suggests that they are bicellar/micellar in nature because the
Fig. 5. Analysis of PEX3(34–373)–lipid interactions by SEC. Recombinant PEX3(34–373) (P3; 50 μg), PI-SUVs (250 μg), or PEX3(34–373) plus PI-SUVs were incubated for 2 h at 37 °C.
After a clarifying spin, the samples were analyzed by SEC. The chromatograms corresponding to PEX3(34–373) (dashed black line), PI-SUVs (solid grey line), and PEX3(34–373) plus
PI-SUVs (solid black line) are shown at the top of the panels. Numbers at the bottom of the chromatograms indicate the fractions collected and analyzed by SDS-PAGE and TLC. The
respective Coomassie Blue-stained gels and TLC plates are shown in the panels below the chromatograms. Note that BSA (66 kDa) was added to all fractions before thrichloroacetic
acid precipitation to control protein recoveries. The positions corresponding to the elution peaks of the standard proteins thyroglobulin (Thy), bovine serum albumin (BSA) and
soybean trypsin inhibitor (STI) are indicated. The asterisk indicates the PEX3(34–373) dimer. Numbers at the left indicate the molecular masses of protein standards in kDa.
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phospholipids have radii of approximately 10 nm [33]. Their small
size and, consequently, their high protein:lipid ratio also explains why
these particles ﬂoat only partially upon centrifugation on Optiprep
gradients.
4. Discussion
This work was triggered by the observation that soluble and
monomeric recombinant PEX3(34–373) forms high molecular mass
aggregates when treated with low concentrations of mild detergents.
Perhaps the best way to understand this property is to assume that the
soluble form of this recombinant protein represents a metastable
conformation stabilized by detergent-sensitive intramolecular hydro-
phobic interactions. Disruption of these interactions would expose
these hydrophobic domains leading to protein multimerization/
aggregation. We hypothesized that this unusual property might
reﬂect some functionally important aspect of this protein and
reasoned that membrane lipids and/or cargo proteins could be the
biologically relevant species interacting with these domains of PEX3.
In this work we provide evidence suggesting that PEX3(34–373)
interacts with membrane lipids. Future work will be necessary to
determine if this domain of PEX3 interacts directly also with cargo
proteins.
The behavior of PEX3(34–373) in the lipid interaction experiments
turned out to be quite complex and at least three different types of
phenomena were observed: (1) association with lipids yielding large
particles with a high lipid:protein (w/w) ratio (sedimentable in alow-speed centrifugation but ﬂoatable; see Materials andmethods for
details); (2) formation of large lipid-free/-poor aggregates (sedi-
mentable but non-ﬂoatable); and (3) incorporation into small
lipoprotein particles (non-sedimentable and partially ﬂoatable). The
ﬁrst phenomenon was evident when using per-SUVs. It is presently
unknown whether the PEX3(34–373)-induced ﬂocculation of per-
SUVs represents aggregation of liposomes or their fusion. The other
two phenomena were observed in experiments performed with PI-
SUVs. Whereas formation of large lipid-free/-poor aggregates of PEX3
(34–373) could be explained by the metastable conformation
hypothesis, the capacity of PEX3(34–373) to form small lipoprotein
particles evokes the properties of the so-called exchangeable
apolipoproteins, e.g., ApoAI and ApoE (e.g., see refs. [34, 35]). These
proteins, particularly rich in amphipathicα-helices, can exist either in
a lipid-free or lipid-bound state. Transition from one state to the other
is accompanied by major rearrangements of the amphipathic α-
helices which are either packed against each other in the lipid free-
state or embracing a disk or a sphere of lipids (reviewed in ref. [34]).
Interestingly, PEX3(34–373) is also particularly enriched in α-helical
structure [31] and several regions of this protein are predicted to fold
into amphipathic α-helices (e.g., residues 167–192, 206–219, 265–
273 and 279–305; hmoment program in the EMBOSS software
package [36]). Thus, the similarities between the effect of PEX3(34–
373) on PI-SUVs and, for example, that of ApoE on artiﬁcial liposomes
[35] may have a common molecular basis. This does not necessarily
imply that PEX3 also has this capacity in vivo because these small
lipoprotein particles were detected only when using liposomes made
of pure PI. It is possible that this in vitro activity reﬂects just the
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lipid bilayer. Nevertheless, considering that lipids in biological
membranes do not exist as homogeneous mixtures, the apolipopro-
tein-like behavior of PEX3(34–373) should be further characterized
because it might provide clues on how mutant yeast strains/cell
lines deﬁcient in the biogenesis of the peroxisomal membrane are
able to generate this membrane system, apparently using a de novo
pathway, when transfected with a functional version of the mutated
gene [37–39].
Regardless of the biological relevance of the lipoprotein particles
detected in this work, our results also suggest that PEX3(34–373)
interacts strongly with artiﬁcial membranes possessing a lipid
composition mimicking the one of the peroxisomal membrane. This
property may have implications on the topology(ies) adopted by
PEX3 at the peroxisomal membrane and thus on its function. Several
models for the membrane topology of PEX3 have been proposed over
the years [19,40–42]. Probably the most consensual is one proposing
that PEX3 has a single transmembrane domain near its N terminus
(amino acids 16–34 in the human protein) and exposes its N terminus
into the lumen of the organelle whereas the bulky part of the protein
(from amino acid 34 to the C terminus) protrudes into the cytosol (see
ref. [18] and references cited therein). Several observations support
this topological model (e.g., ref. [19]) but the idea that amino acid
residues downstream of the proposed transmembrane domain
comprise a single non-membranous domain derives basically from
two ﬁndings. The ﬁrst is that expression of this PEX3 domain in vivo
results in a predominant cytosolic localization [18,19]. However, these
data exclude neither the existence of a small membrane-associated
pool of this truncated protein in the analyzed cells nor the possibility
that the cytosolic population of truncated PEX3 already exists in a
lipidated form. The second regards the fact that recombinant proteins
corresponding to this region of PEX3 can be obtained in a soluble form
in the absence of detergents or other solubilizing agents (see refs.
[14,16,31] and this work). However, as shown here, when PEX3(34–
373) is incubated with liposomes, strong protein–lipid interactions
are established. This is not the behavior one expects for a typical
soluble protein. Rather, it suggests that this domain of PEX3 is
amphitropic.
Interestingly, the lipid-binding activity of PEX3(34–373) is
inhibited by recombinant PEX19. Likewise, the detergent-induced
aggregation of PEX3(34–373) is also partially inhibited by PEX19. It is
presently unknown whether PEX19 competes with lipids/detergents
for PEX3(34–373) binding or if PEX19 stabilizes a PEX3(34–373)
conformation unable to bind these amphipathic molecules. Regard-
less, if we extrapolate the mutually exclusive binding of PEX19 and
membrane lipids to PEX3(34–373) to the in vivo situation then we
have to conclude that this domain of PEX3 is not always in contact
with the lipid bilayer of the peroxisomal membrane. An interesting
scenario emerges from this reasoning. It is possible that this domain of
PEX3 is dynamic in nature and that docking of the PEX19-cargo
protein complex at the peroxisomal membrane and insertion of the
PMP into the organelle membrane involves different PEX3 confor-
mers. In one of these conformers the cytosolic domain of PEX3 would
be in a lipid-free state and thus competent in binding PEX19 or
PEX19–PMP cargo protein complexes, as shown before [14,16]; in the
other, the cytosolic domain of PEX3 would bind membrane lipids and,
presumably, the PMP but not PEX19. The result of this transition
would thus be the dissociation of the PEX19–PMP complex and the
insertion of the PMP into organelle membrane. Further work will be
necessary to test this hypothesis.
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